Randomized Conversion of Calcinurin-Inhibitors (Tacrolimus to Sirolimus) at 6-24 Months Post Transplant in a Prednisone-Free Immunosuppression Regimen: Impact of Incidence of Acute Cellular Rejection, Renal Allograft Function and T Cell Function.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Sirolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacodynamics; Therapeutic Use
- 18 Jan 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 18 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 13 May 2014 Planned End Date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History